Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 9, 2014, Pages 1785-1795

  Marro, M ^a   Nieva, C ^a,b   Sanz Pamplona, R ^c   Sierra, A ^b  

^a ICFO INSTITUT DE CIENCIES FOTONIQUES   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Biomarker; Breast cancer; Epithelial to mesenchymal transition (EMT); Lipid; Metabolism; Raman spectroscopy

Indexed keywords

LIPID; TRYPTOPHAN;

ARTICLE; BIOCHEMISTRY; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL; EPITHELIAL MESENCHYMAL TRANSITION; FATTY ACID ANALYSIS; METASTASIS; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SENSITIVITY AND SPECIFICITY;

BIOMARKER; BREAST CANCER; EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT); LIPID; METABOLISM; RAMAN SPECTROSCOPY;

ALGORITHMS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISCRIMINANT ANALYSIS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEAST-SQUARES ANALYSIS; PHENOTYPE; SPECTRUM ANALYSIS, RAMAN;

EID: 84902440356     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.04.012     Document Type: Article

References (65)

1. Chi V., Semenza G.L. Oncogenic alterations of metabolism. TIBS 1999, 24:68-72.
2. Jones R.G., Thompson C.B. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009, 23:537-548.
3. Menendez J.A., Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 2007, 7:763-777.
4. Chajes V., Lanson M., Fetissof F.L., Huillery C., Bougnoux P. Membrane fatty acids of breast carcinoma: contribution of host fatty acids and tumor properties. Int. J. Cancer 1995, 63:169-175.
5. Hilvo M., Denkert C., Lehtinen L., Müller B., Brockmöller S., Seppänen-Laakso T., Budczies J., Bucher E., Yetukuri L., Castillo S., Berg E., Nygren H., Sysi-Aho M., Griffin J.L., Fiehn O., Loibl S., Richter-Ehrenstein C., Radke C., Hyötyläinen T., Kallioniemi O., Iljin K., Oresic M. Novel therasnostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res. 2011, 71:3236-3245.
6. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.
7. Luo W., Chang R., Zhong J., Pandey A., Semenza G.L. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3367-E3376.
8. Sørlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Lønning P.E., Børresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 2001, 11:10869-10874.
9. Rysman E., Brusselmans K., Scheys K., Timmermans L., Derua R., Munck S., Van Veldhoven P.P., Waltregny D., Daniëls V.W., Machiels J., Vanderhoydonc F., Smans K., Waelkens E., Verhoeven G., Swinnen J.V. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res. 2010, 70:8117-8126.
10. Sørlie T., Tibshirani R., Parker J., Hastie T., Marron J.S., Nobel A., Deng S., Johnsen H., Pesich R., Geisler S., Demeter J., Perou C.M., Lønning P.E., Brown P.O., Børresen-Dale A.L., Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8418-8423.
11. 2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells. PLoS One 2011, 6:e23464. 10.1371/journal.pone.0023464.
12. Sarrió D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008, 68:989-997.
13. Scheel C., Weinberg R.A. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 2012, 22:396-403.
14. Celià-Terrassa T., Meca-Cortés O., Mateo F., de Paz A.M., Rubio N., Arnal-Estapé A., Ell B.J., Bermudo R., Díaz A., Guerra-Rebollo M., Lozano J.J., Estarás C., Ulloa C., Álvarez-Simón D., Milà J., Vilella R., Paciucci R., Martínez-Balbás M., de Herreros A.G., Gomis R.R., Kang Y., Blanco J., Fernández P.L., Thomson T.M. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J. Clin. Invest. 2012, 122:1849-1868.
15. Nieva C., Marro M., Santana-Codina N., Rao S., Petrov D., Sierra A. The lipid phenotype of breast cancer cells characterized by Raman microspectroscopy: towards a stratification of malignancy. PLoS One 2012, 7:e46456. 10.1371/journal.pone.0046456.
16. Creighton C.J., Massarweh S., Huang S., Tsimelzon A., Hilsenbeck S.G., Osborne C.K., Shou J., Malorni L., Schiff R. Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts. Cancer Res. 2008, 68:7493-7501.
17. Vazquez-Martin A., Colomer R., Brunet J., Lupu R., Menendez J.A. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif. 2008, 41:59-85.
18. Hedegaard M., Matthaus C., Hassing S., Krafft C., Diem M., Popp J. Spectral unmixing and clustering algorithms for assessment of single cells by Raman microscopic imaging. Theor. Chem. Acc. 2011, 130:1249-1260.
19. Krafft C., Belay B., Bergner N., Romeike B., Reichart R., Kalff R., Popp J. Advances in optical biopsy-correlation of malignancy and cell density of primary brain tumors using Raman microspectroscopic imaging. Analyst 2012, 137:5533-5537.
20. Miljkovic M., Chernenko T., Romeo M., Bird B., Matthaus C., Diem M. Label-free imaging of human cells: algorithms for image reconstruction of Raman hyperspectral datasets. Analyst 2010, 135:2002-2013.
21. Jaumot J., Gargallo R., de Juan A., Tauler R. A graphical user-friendly interface for MCR-ALS: a new tool for multivariate curve resolution in MATLAB. Chemom. Intell. Lab. Syst. 2005, 76:101-110.
22. Azzouz T., Tauler R. Application of multivariate curve resolution alternating least squares (MCR-ALS) to the quantitative analysis of pharmaceutical and agricultural samples. Talanta 2008, 74:1201-2010.
23. Tauler R., Lacorte S., Guillamon M., Cespedes S., Viana P., Barcelo D. Chemometric modeling of main contamination sources in surface waters of Portugal. Environ. Toxicol. Chem. 2004, 23:565-575.
24. Garrido M., Rius F., Larrechi M. Multivariate curve resolution-alternating least squares (MCR-ALS) applied to spectroscopic data from monitoring chemical reactions processes. Anal. Bioanal. Chem. 2008, 390:2059-2066.
25. Piqueras S., Duponchel L., Tauler R., de Juan A. Resolution and segmentation of hyperspectral biomedical images by Multivariate Curve Resolution-Alternating Least Squares. Anal. Chim. Acta. 2011, 705:182-192.
26. Huang C., Ando M., Hamaguchi H., Shigeto S. Disentangling dynamic changes of multiple cellular components during the yeast cell cycle by in vivo multivariate Raman imaging. Anal. Chem. 2012, 84:5661-5668.
27. Chan J., Lieu D. Label-free biochemical characterization of stem cells using vibrational spectroscopy. J. Biophotonics 2009, 2:656-668.
28. Neugebauer U., Schmid U., Baumann K., Ziebuhr W., Kozitskaya S., Deckert V., Schmitt M., Popp J. Towards a detailed understanding of bacterial metabolism-spectroscopic characterization of Staphylococcus epidermidis. ChemPhysChem 2007, 8:124-137.
29. Harris A.T., Garg M., Yang X.B., Fisher S.E., Kirkham J., Smith D.A., Martin-Hirsch D.P., High A.S. Raman spectroscopy and advanced mathematical modelling in the discrimination of human thyroid cell lines. Head Neck Oncol. 2009, 1:38-49.
30. Bonnier F., Byrne H. Understanding the molecular information contained in principal component analysis of vibrational spectra of biological systems. Analyst 2012, 137:322-332.
31. Marro M., Taubes A., Abernathy A., Balint S., Moreno B., Sanchez-Dalmau B., Martinez-Lapiscina E., Amat-Roldan I., Petrov D., Villoslada P. Dynamic molecular monitoring of retina inflammation by in vivo Raman spectroscopy coupled with multivariate analysis. J. Biophotonics 2013, 10.1002/jbio.201300101.
32. Chambers A.F. MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?. Cancer Res. 2009, 69:5292-5293.
33. Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 1:207-210.
34. Charafe J.E., Ginestier C., Monville F., Finetti P., Adélaïde J., Cervera N., Fekairi S., Xerri L., Jacquemier J., Birnbaum D., Bertucci F. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006, 25:2273-2284.
35. Shi J., Walker M.G. Gene Set Enrichment Analysis (GSEA) for interpreting gene expression profiles. Curr. Bioinforma. 2007, 2:133-137.
36. R: Development Core Team R: A Language and Environment for Statistical Computing 2004, R Foundation for Statistical Computing, Vienna, Austria, (http://www.r-project.org).
37. Gunasinghe N.P., Wells A., Thompson E.W., Hugo H.J. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev. 2012, 31:469-478. 10.1007/s10555-012-9377-5.
38. Tomaskovic-Crook E., Thompson E.W., Thiery J.P. Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res. 2009, 11:213. 10.1186/bcr2416.
39. Lee S.J., Seol H.J., Lee H.W., Kang W.Y., Kang B.G., Jin J., Jo M.Y., Jin Y., Lee J.I., Joo K.M., Nam D.H. Gene silencing of c-Met leads to brain metastasis inhibitory effects. Clin. Exp. Metastasis 2013, 30:845-854.
40. Hazan R.B., Phillips G.R., Qiao R.F., Norton L., Aaronson S.A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 2000, 148:779-790.
41. Hartsuiker L., Zeijen N.J., Terstappen L.W., Otto C. Analyst 2010, 135:3220-3226.
42. Movasaghi Z., Rehman S., Rehman I. Raman spectroscopy of biological tissues. Appl. Spectrosc. Rev. 2007, 42:493-541.
43. Krafft C., Neudert L., Simat T., Salzer R. Near infrared Raman spectra of human brain lipids. Spectrochim. Acta A 2005, 61:1529-1535.
44. Devpura S., Thakur J., Sethi S., Naik V., Naik R. Diagnosis of head and neck squamous cell carcinoma using Raman spectroscopy: tongue tissues. J. Raman Spectrosc. 2012, 43:490-496.
45. Gelder J., Gussem K., Vandenabeele P., Moens L. Reference database of Raman spectra of biological molecules. J. Raman Spectrosc. 2007, 38:1133-1147.
46. Santana N., Nieva C., Marro M., Rao S., Petrov D., Sierra A. Raman microspectroscopy is a tool to identify the metastatic ability of breast tumors. International Workshop on Biophotonics 2011, 10.1109/IWBP.2011.5954866.
47. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15545-15550.
48. Jechlinger M., Grunert S., Tamir I.H., Janda E., Lüdemann S., Waerner T., Seither P., Weith A., Beug H., Kraut N. Expression profiling of epithelial plasticity in tumor progression. Oncogene 2003, 22:7155-7169.
49. Koppenol W.H., Bounds P.L., Dang C.V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 2011, 11:325-337.
50. Papageorgis P., Lambert A.W., Ozturk S., Gao F., Pan H., Manne U., Alekseyev Y.O., Thiagalingam A., Abdolmaleky H.M., Lenburg M., Thiagalingam S. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res. 2010, 70:968-978.
51. Chinnaiyan P., Kensicki E., Bloom G., Prabhu A., Sarcar B., Kahali S., Eschrich S., Qu X., Forsyth P., Gillies R. The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res. 2012, 72:5878-5888.
52. Antalis C.J., Uchida A., Buhman K.K., Siddiqui R.A. Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification. Clin. Exp. Metastasis 2011, 28:733-741.
53. Abramczyk H., Brozek-Pluska B., Surmacki J., Jablonska-Gajewicz J., Kordek R. Raman optical biopsy of human breast cancer. Prog. Biophys. Mol. Biol. 2012, 108:74-81.
54. Abramczyk H., Brozek-Pluska B., Surmacki J., Jablonska J., Kordek R. Raman spectroscopy and imaging: applications in human breast cancer diagnosis. Analyst 2012, 137:3773-3781.
55. Travers M.T., Gow I.F., Barber M.C., Thomson J., Shennan D.B. Indoleamine 2,3-dioxygenase activity and l-tryptophan transport in human breast cancer cells. Biochim. Biophys. Acta 2004, 1661:106-112.
56. Levina V., Su Y., Gorelik E. Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation. Clin. Dev. Immunol. 2012, 173029. 10.1155/2012/173029.
57. Kumar L.D., Clarke A.R. Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications. Adv. Drug Deliv. Rev. 2007, 59:87-100.
58. Huang L., Zheng M., Zhou Q.M., Zhang M.Y., Jia W.H., Yun J.P., Wang H.Y. Identification of a gene-expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma. Cancer 2011, 117:3363-3373.
59. Platten M., Wick W., Van den Eynde B.J. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res. 2012, 72:5435-5440.
60. Creighton C.J., Chang J.C., Rosen J.M. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J. Mammary Gland Biol. Neoplasia 2010, 15:253-260.
61. Fuxe J., Vincent T., Garcia de Herreros A. Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010, 9:2363-2674.
62. Stresing V., Baltziskueta E., Rubio N., Blanco J., Arriba M.C., Valls J., Janier M., Clézardin P., Sanz-Pamplona R., Nieva C., Marro M., Petrov D., Sierra A. Peroxiredoxin 2 specifically regulates the oxidative and metabolic-stress response of human breast cancer cells. Oncogene 2012, 32:724-735.
63. Simon R. Challenges of microarray data and the evaluation of gene expression profile signatures. Cancer Invest. 2008, 26:327-332.
64. Drasin D.J., Robin T.P., Ford H.L. Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity. Breast Cancer Res. 2011, 13:226. 10.1186/bcr3037.
65. Simpson N.E., Tryndyak V.P., Beland F.A., Pogribny I.P. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression. Breast Cancer Res. Treat. 2012, 133:959-968.